Difference between revisions of "Team:Munich/Amplification"

Since real-world patient samples contain only traces of pathogens (attomolar at the lowest), any detection method relying on binding affinity (such as Cas13a with target RNA) needs prior amplification of the detected molecule to concentrations within the range of the Kd. After we confirmed that the detection limit of Cas13a is in the nanomolar region, we had to tackle the problem of low target concentrations in medical samples. We explored different amplification methods that would be simple and stable on our transportable platform. We wanted to incorporate isothermal reactions on paper with lyophilized reaction mixes. Therefore, we explored isothermal PCR methods coupled to in vitro transcription . We chose isothermal methods for signal amplification since isothermal techniques come with the potential of simplified hardware design which would lead to decreased production and development costs. PCR using a proper thermocycler and well-defined cycling times also require a trained personnel to use them, which does not fit to our goal of a distributable diagnosis device. Eventually, we would need to detect both DNA and RNA samples by using either a reverse transcriptase coupled isothermal recombinase polymerase amplification and subsequent in vitro transcription for RNA targets or leaving out the step of reverse transcription for DNA targets. We term this amplification process RT-RPA-TX.

Recombinase Polymerase Amplification

The Recombinase Polymerase Amplification (RPA) developed by TwistDx is an isothermal amplification method for DNA. Rather than melting the double strand and annealing the primers through temperature cycles, it uses a recombinase that binds the primers and assists in the annealing process. Another protein, single-strand DNA binding protein (SSB) promotes the binding of the primers to the recombinase in this process. Hence, the first step in the development of an isothermal amplification method of an RNA signal via RT-RPA-TX was testing the Recombinase Polymerase Amplification (RPA) itself in bulk. For this, we took our previously cloned His-tagged TEV Protease (BBa_K2323002 improved from BBa_K1319008) and ran dummy PCR reactions using the TwistDx RPA Kit and the universal biobricks primers VF2 (BBa_G00100) and VR (BBa_G00101). We ran the provided test reaction of the TwistDx RPA Kit as a positive control (TwistAmp exo). The results are shown in Figure 1. The first point to note is that PCR primers and RPA primers have different requirements, due to the need for affinity of the recombinase to the primers (RPA primers tend to be shorter with a higher GC content). Therefore VF2 and VR might not be ideal primers for RPA. The second point is that RPA's optimum amplification length is 500bp. For longer amplifications, it is possible that the polymerase falls off the strand. This could explain why we see at maximum a band of 500bp, and shorter bands, although our amplicon should be 1262bp. We could therefore see that amplification using RPA was possible in bulk, but that primer design would need to be optimized for our final product.

To better assess the RPA reaction, we therefore constructed a benchmark plasmid coding for 3 of our target sequences (E. coli, B. subtilis and Norovirus) under the control of a T7 promoter. It is flanked by VF2 and VR primers binding sequences, so that it can be amplified similarly to our first His-TEV construct, but the amplicon is only 194bp. This was a great benchmarking sequence, as the plasmid could be used for amplification from lyzed cells (as would be the case with a real sample), the sequence was short enough, could be coupled with transcription and consisted of relevant targets for our read-out.

RPA on paper

The next step was to bring the RPA reaction on paper. For this, we lyophilized the reaction mixture provided by TwistDx on paper and tried to run RPA reactions directly from it by inserting the blotting paper into the PCR tube. Activity could be shown on an agarose gel but time-stability experiments showed that the RPA kit activity decreases quickly. In the user's manual, it is stated that after breaking the seal, one should use up the reaction mix in the next hour. We can confirm this statement since activity declined rapidly after as little as two hours and was non-existent after 24 hours, as is visible in Figure 2. Furthermore, temperature seems to be a very important factor during amplification using RPA. The samples incubated at of 20 °C, though still active, showed dramatically decreased activity compared to the same samples at 37°C.

For usage of RPA on a detection device that does not require purification of the sample, the reaction needs to take place in the environment of a lysate with cell debris and released proteins from the cell. In order to see whether this is achievable, we performed a colony-PCR like setting of RPA using a E. coli culture in LB-medium with OD=1.0 and ran a normal RPA of purified plasmid as a control. As our first PCR produced too long of an amplicon, we changed to a shorter PCR scheme, which should lead to an amplification of 194bp. The results are shown in Figure 3. A band at the expected length is visible in both the control condition and the E.coli environment. We observed that the yield measured by gel quantification was approximately the same.

Since the stability of RPA on paper for a long period of time would be crucial to our diagnosis device, we considered the possible reasons for the unstability of our RPA mix. We could think of two factors affecting the stability: humidity and temperature. As we want our platform to be distributable across the world, we needed to test those hypothesis. We found out, that the unstability is mainly cause by exposure to air, presumably humidity. We could dramatically increase stability when covering the paperstrip in a plastic Petri dish and sealing it with Parafilm. The stability was increased when keeping the paperstrip at 4°C, but the RPA was anyway still active after 24 hours storage at room temperature (when protected in a sealed environment). The results are shown in Figure 4. We did not have time to conduct long-term storage tests, but we are hopeful that with the right sealing strategy, the RPA could still be active on paper after a year.